Interestingly, both RRM2 and DCK are reported to be associated with the drug sensitivity of gemcitabine (a common chemotherapeutic drug for pancreatic cancer and many other types of cancer). The gene discussed is RRM2; the disease is familial pancreatic carcinoma.